Abstract:BACKGROUND: Bone marrow mesenchymal stem cells (BMSCs) can differentiate into hepatocyte-like cells in vivo and vitro and show hepatocyte function such as synthesis and secretion. OBJECTIVE: To induce and differentiate BMSCs into hepatic cells, which are transplanted into homogeneitic rat livers that had fibrous degenerated, and to observe the distribution, differentiation and effects of the hepatocytes on hepatic function. DESIGN, TIME AND SETTING: Randomized controlled animal experiment was performed at the Laboratory of Hospital Affiliated to Luzhou Medical College from June 2007 to March 2008. MATERIALS: A total of 10 clean male Sprague Dawley rats weighing 100 g were selected to culture BMSCs and to be induced and differentiated into hepatocyte-like cells. A total of 75 clean male Sprague Dawley rats weighing 200-250 g were randomly divided into hepatocyte-like cell transplantation group (n=30), model control group (n=30) and normal control group (n=15). Rats in the hepatocyte-like cell transplantation group and model control group intraperitonealy underwent carbon tetrachloride to prepare animal models of hepatic fibrosis. METHODS: Rats in the model control group and normal control group were subjected to serum-free low-glucose DMEM via portal vein infusion. Rats in the hepatocyte-like cell transplantation group received DAPI labelled hepatocyte-like cells. All rats were sacrificed to obtain liver and serum samples at 1, 2, 3 and 4 weeks following transplantation. MAIN OUTCOME MEASURES: Degree of the hepatic fibrosis was evaluated though Masson triple stain. Frozen sections were made to detect transformation of livers which had been transplanted cells with a fluorescence microscope. Serum the parameters of liver function and hepatic fibrosis were detected by the automatic biochemistry analyzer and radio-immunifaction method. RESULTS: Transplanted cells from the blood vessels gradually accessed into the liver, and eventually distributed between the liver cells scattered. But after three weeks of transplantation, fluorescence obviously decayed. At week 2, liver false lobular gradually absorbed or dissipated, and fibrosis significantly milder than the model control group, with collagen staining lighting and distributing in the fiber interval and portal area, and liver cells presented Balloon-like degeneration. At week 4, liver cells arranged in normal. Dot necrosis was occasionally found without fiber interval. No significant differences in the parameters of liver function and hepatic fibrosis were found compared with the normal control group(P > 0.05). CONCLUSION: Induced hepatocyte-like cells could engraft into fibrotic liver after transfusion as early as on the 7th day and localized in collection tube region and liver sinus. Results of biochemistry detection showed that the engrafted hepatocyte-like cells could substitute liver function partly.

Autologous Bone Marrow-Derived Mesenchymal Stem Cell Transplantation Promotes Liver Regeneration after Portal Vein Embolization in Cirrhotic Rats

The preliminarily investigation of therapeutic effects of mesenchymai stem cells on rat fulminant hepatic failure

The Effect of Vascular Endothelial Growth Factor on Bone Marrow Mesenchymal Stem Cell Engraftment in Rat Fibrotic Liver Upon Transplantation

Mesenchymal Stem Cells with Enhanced Bcl-2 Expression Promote Liver Recovery in a Rat Model of Hepatic Cirrhosis.

Effects Of Allogeneic Mesenchymal Stem Cell Transplantation In The Treatment Of Liver Cirrhosis Caused By Autoimmune Diseases

Transplantation of bone marrow-derived hepatocyte-like cells via the portal vein in rat hepatic fibrosis models

Autologous mesenchymal stem cell transplantation for end-stage liver cirrhosis :a Meta-analysis

[Study of Bone Mesenchymal Stem Cells Tropism for Hepatic Tumors and Effect on the Form of Tumor Stromal].

Autologous Adipose Tissue-Derived Mesenchymal Stem Cells Are Involved in Rat Liver Regeneration Following Repeat Partial Hepatectomy

Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells Attenuate Hepatic Ischemia-Reperfusion Injury by Suppressing Oxidative Stress and Inhibiting Apoptosis in Rats

Differentiation and Migration of Bone Marrow Mesenchymal Stem Cells Transplanted Through the Spleen in Rats with Portal Hypertension.

Granulocyte Colony-Stimulating Factor-Mobilized Autologous Bone Marrow Stem Cells Promote the Liver Regeneration of Partial Liver Transplant: an Experiment with Rats

Research on the Effect of Allogeneic MSC Transplantation Through Portal Vein in Rat Partial Hepatectomy Model

Adipose derived mesenchymal stem cells transplantation via portal vein improves microcirculation and ameliorates liver fibrosis induced by CCl4 in rats

Transplantation of Autologous Mesenchymal Stem Cells for End-Stage Liver Cirrhosis: a Meta-Analysis Based on Seven Controlled Trials.

Synergistic Hepatoprotective Effects of Mesenchymal Stem Cells and Platelet-Rich Plasma in a Rat Model of Bile Duct Ligation-Induced Liver Cirrhosis

Hypoxia preconditioned bone marrow mesenchymal stem cells promote liver regeneration in a rat massive hepatectomy model

The Experimental Study of BMSCs Transplanted into Rat Models of Liver Cirrhosis

Reconstruction of hepatic functions after bone marrow mesenchymal stem cells transplantation

Intra-portal Transplantation of Bone Marrow Stromal Cells Ameliorates Liver Fibrosis in Mice

Bone Marrow Mesenchymal Stem Cells Promote Graft Regeneration after Small-for-size Liver Transplantation in Rats